Octave Specialty Group, Inc. Form 8-K Filing

On April 1, 2026, Octave Specialty Group, Inc. (the "Company") and its subsidiaries entered into the First Amendment to Credit Agreement and Other Loan Documents. This amendment provides an additional term loan of $40,000,000, bringing the total outstanding term loans to $139,375,000 as of April 1, 2026. The proceeds will be used to fund the payment of Cirrata UK's obligation to honor put rights exercised by minority shareholders of Octave Specialty Limited. The Company pledged its ownership interests in Everspan Holdings, LLC as collateral.